Johnson & Johnson reported $23.31B in Sales Revenues for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbott ABT:US $ 10223M 233M
Abbvie ABBV:US $ 13959M 949M
Abiomed ABMD:US $ 252.58M 11.34M
Amgen AMGN:US $ 6526M 625M
AstraZeneca AZN:LN 8220M 900M
Astrazeneca AZN:US $ 8220M 900M
Baxter International BAX:US $ 3098M 152M
Bayer BAYN:GR € 10854M 1474M
Becton, Dickinson and BDX:US $ 4890M 17M
Biogen BIIB:US $ 2775M 81M
Boston Scientific BSX:US $ 3077M 325M
Bristol Myers Squibb BMY:US $ 11703M 630M
Cardiovascular Systems CSII:US $ 70.99M 7.71M
Conmed CNMD:US $ 255.16M 22.48M
Cooper Companies COO:US $ 763.4M 43.9M
Dexcom DXCM:US $ 595.1M 90.1M
Edwards Lifesciences EW:US $ 1376M 159.4M
Eli Lilly And LLY:US $ 6740.1M 65.5M
Gilead Sciences GILD:US $ 6217M 206M
GlaxoSmithKline GSK:LN 8092M 674M
Globus Medical GMED:US $ 251.02M 23.67M
Hill Rom HRC:US $ 717.7M 44.3M
Hologic HOLX:US $ 1168.3M 369.3M
Insulet PODD:US $ 263.2M 10.9M
Integra Lifesciences IART:US $ 389.99M 29.92M
Intuitive Surgical ISRG:US $ 1464M 171.9M
Johnson & Johnson JNJ:US $ 23312M 991M
Medtronic MDT:US $ 7987M 201M
Merit Medical Systems MMSI:US $ 280.32M 31.41M
Merk MRK:US $ 11402M 678M
Novartis NOVN:VX SF 13294M 600M
Nuvasive NUVA:US $ 294.83M 23.58M
Pfizer PFE:US $ 18977M 4395M
Regeneron Pharmaceuticals REGN:US $ 5138.5M 2609.8M
Stryker SYK:US $ 4294M 341M
Tandem Diabetes Care TNDM:US $ 172.14M 31.1M
Teva Pharmaceutical TEVA:IT 3.91B 72M
Vertex Pharmaceuticals VRTX:US $ 1793.37M 69.06M
Zimmer Biomet Holdings Inc ZBH:US $ 2.03B 179.5M
Zoetis ZTS:US $ 1948M 77M